Skip to main content
Veterinary Medicines

Nobilis Rismavac Zawiesina i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań

Authorised
  • Marek's disease virus, strain CVI-988 (Rispens), Live

Product identification

Medicine name:
Nobilis Rismavac Zawiesina i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań
Active substance:
  • Marek's disease virus, strain CVI-988 (Rispens), Live
Target species:
  • Chicken (hen)
Route of administration:
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Marek's disease virus, strain CVI-988 (Rispens), Live
    0.69
    tissue culture infective dose 50
    /
    1.00
    tissue culture infective dose 50
Pharmaceutical form:
  • Concentrate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Chicken (hen)
      • Meat and offal
        0
        day
  • Intramuscular use
    • Chicken (hen)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD03
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 0497
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."